SCYNEXIS, Inc. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value
SCYNEXIS, Inc. (SCYX) had Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value of $986.00 thousand as of 2018-12-31, per its 10-K filed 2019-03-14.
Discontinued › Notes › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue · last filed 2019-03-14
- 2018-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $986.00K.
- 2018-09-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $5.24M.
- 2018-06-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $12.17M.
- 2018-03-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $9.30M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value |
|---|---|
| 2018-12-31 | $986.00K 10-K · filed 2019-03-14 |
| 2018-09-30 | $5.24M 10-Q · filed 2018-11-13 |
| 2018-06-30 | $12.17M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $9.30M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $3.87M 10-K · filed 2019-03-14 |
| 2017-09-30 | $3.79M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $2.15M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $5.08M 10-Q · filed 2017-05-08 |
| 2016-12-31 | $6.60M 10-K · filed 2018-03-13 |
| 2015-12-31 | $0.00 10-K · filed 2017-03-13 |
| 2014-12-31 | $0.00 10-K · filed 2016-03-07 |
| 2014-09-30 | $0.00 10-Q · filed 2015-11-13 |
| 2014-06-30 | $0.00 10-Q · filed 2015-08-19 |
| 2014-03-31 | $10.00M 8-K · filed 2015-10-30 |
| 2013-12-31 | $12.24M 10-K · filed 2016-03-07 |
| 2013-09-30 | $2.52M 10-Q · filed 2014-11-13 |
| 2013-06-30 | $1.85M 10-Q · filed 2014-11-13 |
| 2012-12-31 | $683.00K 8-K · filed 2015-10-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |